Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IFN-epsilon and Hormonal Contraceptive Modulation of the Risk of HIV Acquisition, Part 1: Expression in the Female Reproductive Tract

NCT02416154 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT02416154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02416154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IFN-epsilon and Hormonal Contraceptive Modulation of the Risk of HIV Acquisition, Part 1: Expression in the Female Reproductive Tract
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Completed
Start date
July 31, 2015
Completion date
May 31, 2020
Enrollment
32 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

interferon expression in the female reproductive tract